• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

data

Biomimesys

In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology

Few weeks ago, the Hong Kong–based company Insilico Medicine announced the beginning of a phase 1 clinical trial concerning a potential therapy for idiopathic pulmonary fibrosis. The event might have gone unnoticed but the way to find this drug was exceptional: it was designed “from scratch” by a combination of Read more…

By Grégory MAUBON, 4 weeks4 weeks ago
Conferences & Webinars

We were at the #WestDataFestival to talk about AI!

It was a real pleasure for us to be invited at the last West Data Festival, to present our last developments in Artificial Intelligence dedicated to picture analysis. We warmly thank the organizers, Laval Mayenne Technopole and ATLANPOLE biotérapies for this opportunity. We also thank Laval Virtual to help us Read more…

By Grégory MAUBON, 1 year4 months ago
HCS, HCA & Biology

Deep learning for biology is useful (but not easy to understand)

Deep Learning is a set of technologies which use huge amount of data to predict behaviors thanks to hidden (or not) signals inside. In this article for example, we see how a collaboration between Google scientists and Steve Finkbeiner’s use brain cells pictures to automatize “live / dead” classification, and Read more…

By Grégory MAUBON, 3 years3 years ago
News

Ready to ELRIGfr Monaco with a special workshop on augmented reality ?

Discover how immersive technologies could help you in laboratories

By Nathalie MAUBON, 3 years4 months ago
HCS, HCA & Biology

La Donnée : l’ADN des sciences de la vie

De l’importance des données dans les sciences de la vie

By Grégory MAUBON, 4 years4 months ago
HCS, HCA & Biology

Comparing high content screening results

High Content – Less Mess, More Mesh

By Julian Bursztyka, 4 years4 years ago
HCS, HCA & Biology

Φ-score to replace Z score for phenotypic screening

The data analysis and statistics, especially the Z-score that everybody knows, need to be reviewed. Guyon et al boast Φ-score.

By Nathalie MAUBON, 6 years4 years ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • The importance of extracellular matrix in cancers
  • Webinar “Applications for 3D in vitro models with BIOMIMESYS® Adipose Tissue and preview of future BIOMIMESYS® Skin” (April 20 & 22)
  • Lucille joins us to develop hepatocellular models and hiPSCs-derived liver organoids
  • Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models
  • In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress